Magnetic bead and magnetic bead reagent

By covering the magnetic metal particles with a thickness of more than 15 nm and optimizing the metal ion concentration of the magnetic beads, the problems of slow magnetic separation speed and metal dissolution are solved, and efficient biological substance extraction and corrosion resistance of the magnetic beads are achieved.

CN118904277APending Publication Date: 2024-11-08SEIKO EPSON CORP
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
CN202410550058.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2023-05-08
Filing Date
2024-05-06
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

The existing magnetic beads move slowly during magnetic separation, resulting in low extraction efficiency, and the magnetic metal particle cores covered with multi-layered layers of inorganic materials are prone to dissolution of metal ions, hindering the extraction and recovery of biological substances.

Method used

Magnetic metal particles with an inorganic oxide covering film with an average thickness of more than 15 nm were used to optimize the supernatant metal ion concentration of more than 0.01 ppm and less than 5.00 ppm by specific hydrochloric acid impregnation test, and combine with high-frequency inductively coupled plasma emission spectrum. The metal ion concentration was determined by analytical method to ensure the corrosion resistance and efficient extraction ability of the magnetic beads.

Benefits of technology

The rapid magnetic separation of magnetic beads and efficient extraction of biological substances are achieved, which reduces metal ion dissolution, improves the extraction efficiency and corrosion resistance of magnetic beads.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118904277A_ABST
    Figure CN118904277A_ABST
Patent Text Reader

Abstract

The invention provides a magnetic bead and a magnetic bead reagent. A magnetic bead characterized by comprising: magnetic metal particles; and a cover film which covers the surface of the magnetic metal particles, contains an inorganic oxide, and has an average thickness of 15 nm or more, and the metal ion concentration of a supernatant is 0.01 ppm or more and 5.00 ppm or less when the magnetic beads are subjected to: an operation for preparing a first mixture by mixing 0.1 g of ethylenediamine tetraacetic acid, 5 mL of pure water, and 100 mg of the magnetic beads; mixing the first mixture with 5mL of hydrochloric acid with the concentration of 10mM to obtain a second mixture, and then stirring the second mixture for 30 minutes by using a vortex mixer; and standing the stirred second mixture for 1 day, collecting the supernatant, and determining the metal ion concentration of the supernatant by high-frequency inductively coupled plasma emission spectrometry.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to magnetic beads and magnetic bead reagents. Background Art

[0002] In recent years, the demand for the inspection of biological substances has been increasing in the fields of diagnosis or life sciences in the medical field. Among the biological substance inspection methods, the PCR (Polymerase chain reaction) method is a method of extracting nucleic acids such as DNA (deoxyribonucleic acid) or RNA (ribonucleic acid), specifically amplifying the nucleic acids and detecting them. In such a process of inspecting biological substances, it is first necessary to extract the substance to be inspected from the sample. In the extraction of the biological substance, the magnetic separation method using magnetic beads is widely used. In the magnetic separation method, magnetic beads having the function of carrying the biological substance to be extracted are used to extract the biological substance by applying a magnetic field. Specifically, after the magnetic beads having the carrying capacity of the substance to be inspected on the surface are dispersed in the dispersion medium, the obtained dispersion is mounted on a magnetic field generating device such as a magnetic stand, and the magnetic field is repeatedly turned on and off. Thus, the substance to be inspected is extracted. Such a magnetic separation method is a method of separating and recovering the magnetic beads by magnetic force, so a rapid separation operation can be performed.

[0003] In addition, the same magnetic separation method is used not only in the extraction by PCR method but also in the fields of protein purification, separation and extraction of exosomes and cells.

[0004] For example, Patent Document 1 discloses metal particles for magnetic beads, wherein a magnetic metal particle core having an average particle size of 10 μm or less and composed mainly of a magnetic metal is covered with two or more different inorganic materials in multiple layers. According to such metal particles, since the inorganic materials cover the magnetic metal particle core in multiple layers, the dissolution of the metal into the solvent can be suppressed.

[0005] Patent Document 1: Japanese Patent Application Publication No. 2010-156054

[0006] However, in the metal particles described in Patent Document 1, the inorganic material covers the magnetic metal particle core in multiple layers. Therefore, the moving speed of the metal particles when attracted by the applied magnetic field is low, and magnetic separation requires time. On the other hand, when the amount of inorganic material covering the magnetic metal particle core is reduced, the amount of metal leaching may increase. When the amount of metal leaching increases, the leached metal will hinder the extraction and recovery of biological substances.

[0007] Therefore, it has become a technical problem to realize magnetic beads that can rapidly perform magnetic separation and have high extraction efficiency for biological substances. Summary of the invention

[0008] The magnetic beads involved in the application example of the present invention have:

[0009] Magnetic metal particles; and

[0010] A covering film covers the surface of the magnetic metal particles, contains an inorganic oxide, and has an average thickness of 15 nm or more.

[0011] When the magnetic beads are subjected to the following operation, the metal ion concentration of the supernatant is 0.01 ppm or more and 5.00 ppm or less:

[0012] The operation of preparing a first mixture is to mix 0.1 g of ethylenediaminetetraacetic acid (EDTA), 5 mL of pure water and 100 mg of the magnetic beads;

[0013] After mixing the first mixture with 5 mL of 10 mM hydrochloric acid to obtain a second mixture, stirring the second mixture for 30 minutes using a vortex mixer; and

[0014] After the stirred second mixture is left to stand for 1 day, the supernatant is collected, and the metal ion concentration of the supernatant is measured by high-frequency inductively coupled plasma (ICP) emission spectrometry.

[0015] The magnetic bead reagent involved in the application example of the present invention comprises:

[0016] Magnetic beads according to an application example of the present invention; and

[0017] A dispersion medium is provided to disperse the magnetic beads. BRIEF DESCRIPTION OF THE DRAWINGS

[0018] Figure 1 This is a process diagram for explaining an example of a method for extracting a biological substance.

[0019] Figure 2 It is used to illustrate Figure 1 Schematic diagram of the method for extracting biological material is shown.

[0020] Figure 3 It is used to illustrate Figure 1 Schematic diagram of the method for extracting biological material is shown.

[0021] Figure 4 It is used to illustrate Figure 1 Schematic diagram of the method for extracting biological material is shown.

[0022] Figure 5 It is used to illustrate Figure 1 Schematic diagram of the method for extracting biological material is shown.

[0023] Figure 6 It is used to illustrate Figure 1Schematic diagram of the method for extracting biological material is shown.

[0024] Figure 7 It is a cross-sectional view showing the magnetic bead involved in the embodiment.

[0025] Figure 8 Yes means Figure 7 A cross-sectional view of a modified example of a magnetic bead.

[0026] Description of Reference Numerals

[0027] 1: container; 2: magnetic beads; 2A: magnetic beads; 3: liquid; 4: magnetic bead dispersion; 5: magnet; 6: pipette; 22: magnetic metal particles; 24: covering film; 40: dispersion medium; 42: container; 44: pipette; S102: dissolution / adsorption process; S108: cleaning process; S110: dissolution process. DETAILED DESCRIPTION

[0028] Hereinafter, preferred embodiments of the magnetic beads and magnetic bead reagent of the present invention will be described in detail based on the drawings.

[0029] The magnetic beads involved in the embodiment are a group of particles that adsorb biological substances and are used in magnetic separation. Magnetic separation is a technology that applies an external magnetic field to a container containing a solid phase containing magnetic beads and a liquid phase containing a dispersion medium, and separates the solid phase and the liquid phase by magnetically attracting the solid phase.

[0030] Biological substances refer to substances such as nucleic acids such as DNA or RNA, proteins, sugars, various cells such as cancer cells, peptides, bacteria, viruses, etc. It should be noted that nucleic acids may also exist in a state contained in biological samples such as cells or biological tissues, viruses, bacteria, etc. Such biological substances are extracted, for example, through the processes of dissolution, adsorption, washing, and dissolution, and are provided for inspection, etc. By magnetically separating the magnetic beads adsorbed with biological substances, it is possible to easily purify and extract biological substances.

[0031] 1. Methods for extracting biological substances

[0032] An example of a biological substance extraction method using magnetic separation is described below. It should be noted that in the following description, the biological substance is nucleic acid as an example.

[0033] Figure 1 This is a process diagram for explaining an example of a method for extracting a biological substance. Figures 2 to 6 It is used to illustrate Figure 1 Schematic diagram of the method for extracting biological material is shown.

[0034] Figure 1The biological substance extraction method shown includes a dissolution and adsorption step S102, a washing step S108, and an elution step S110. Each step will be described below in order.

[0035] 1.1. Dissolution and adsorption process

[0036] In the dissolution and adsorption step S102, first, Figure 2 As shown, a magnetic bead dispersion 4 (magnetic bead reagent) containing magnetic beads 2 and a dispersion medium 40 is prepared in a container 42 .

[0037] The magnetic bead dispersion 4 is stirred thoroughly in the container 42. As a result, the magnetic beads 2 are uniformly dispersed in the magnetic bead dispersion 4. Then, a predetermined amount of the magnetic bead dispersion 4 is collected from the container 42 by a pipette 44 or the like and dispensed into the container 42. Figure 3 If the concentration distribution of the magnetic bead dispersion 4 is uniform, the target amount of magnetic beads 2 is added to the container 1 through the dispensing operation.

[0038] Next, the sample containing nucleic acid and the dissolving adsorption solution are placed in Figure 3 Then, the contents of the container 1 are mixed. Thus, Figure 4 As shown, magnetic beads 2 are dispersed in liquid 3 in container 1. Since nucleic acids are usually contained in cell membranes and nuclei, the so-called outer shell of the cell membrane or nucleus is dissolved and removed by the dissolving action of the dissolving and adsorbing liquid, and the nucleic acid is taken out. Then, the nucleic acid is adsorbed on the magnetic beads 2 by the adsorption action of the dissolving and adsorbing liquid.

[0039] As the dissolving and adsorbing liquid, for example, a liquid containing a chaotropic substance is used. The chaotropic substance has the function of generating chaotropic ions in the aqueous solution, reducing the interaction of water molecules, thereby destabilizing the structure, and assisting the adsorption of nucleic acids to the magnetic beads 2 .

[0040] It should be noted that, in the case of nucleic acid, especially RNA extraction, it is preferred to add acid or the like to make the liquid 3 in the container 1 acidic. RNA monomers are more easily dissolved in polar solvents than DNA because they contain ribose. In the case of using this difference to separate RNA and DNA, after dissolving and removing the outer shell, for example, acid can be added to make the liquid 3 acidic. Then, a non-polar solvent such as phenol or chloroform is added to the liquid 3. As a result, the DNA is transferred to the non-polar solvent, while the RNA remains in the polar solvent. As a result, RNA and DNA can be separated and RNA can be extracted.

[0041] When extracting RNA, the pH of the liquid 3 in the container 1 is preferably 5.0 or less, more preferably 2.0 or more and 4.0 or less. As a result, the ionization equilibrium of the phosphate group contained in the RNA is biased toward the hydroxyl group, so the RNA is particularly easily dissolved in a polar solvent. Therefore, the extraction efficiency of the RNA can be further improved.

[0042] 1.1.1. Magnetic separation operation

[0043] In the dissolution and adsorption step S102, an external magnetic field is applied to the magnetic beads 2 adsorbed with nucleic acid to perform magnetic attraction. As a result, the magnetic beads 2 are moved to the inner wall of the container 1 and fixed. As a result, Figure 5 As shown, the magnetic beads 2 as a solid phase and the liquid 3 as a liquid phase can be separated. In this specification, the operation of applying such an external magnetic field to fix the magnetic beads 2 is referred to as a "magnetic separation operation."

[0044] Before the magnetic separation operation is performed, the contents of the container 1 are stirred as necessary. This increases the probability that the nucleic acid is adsorbed by the magnetic beads 2. For stirring, for example, a vortex mixer, a manual shaker, a pipette, etc. are used.

[0045] When applying the external magnetic field, for example, a magnet 5 disposed on the side of the container is used. The magnet 5 may be an electromagnet or a permanent magnet. When the external magnetic field acts on the magnetic beads 2, the magnetic beads 2 move toward the magnet 5.

[0046] 1.1.2. Liquid discharge operation

[0047] In the dissolution and adsorption step S102, the magnetic beads 2 are fixed to the inner wall of the container 1. Figure 6 As shown, the liquid 3 retained at the bottom of the container 1 is sucked and discharged using, for example, a pipette 6. In this specification, such an operation of discharging the liquid 3 is referred to as a "liquid discharge operation." The magnetic beads 2 adsorbed with nucleic acid remain in the container 1 through the liquid discharge operation.

[0048] It should be noted that after the liquid discharge operation is performed, acceleration may be applied to the container 1 as needed. This allows the liquid 3 attached to the magnetic beads 2 to be shaken off, thereby reducing the amount of liquid 3 that cannot be separated. The acceleration may be centrifugal acceleration. A centrifuge may be used to impart the centrifugal acceleration.

[0049] 1.2. Cleaning process

[0050] In the washing step S108, the magnetic beads 2 with the nucleic acid adsorbed thereon are washed. Washing is an operation of removing foreign matter adsorbed on the magnetic beads 2 by bringing the magnetic beads 2 with the nucleic acid adsorbed thereon into contact with a washing solution and then separating the washing solution from the washing solution again.

[0051] Specifically, after a washing solution is added to the container 1 containing the magnetic beads 2 adsorbing nucleic acid, the aforementioned magnetic separation operation and liquid discharge operation are performed again.

[0052] Among them, in the magnetic separation operation, first, a cleaning solution is supplied into the container 1 through a pipette or the like. Then, the magnetic beads 2 and the cleaning solution are stirred. Thus, the cleaning solution contacts the magnetic beads 2, and the magnetic beads 2 adsorbed with nucleic acid are cleaned. During the stirring, for example, a vortex mixer, a manual oscillator, a pipette, etc. are used. In addition, at this time, the application of the external magnetic field can also be temporarily turned off. Thus, since the magnetic beads 2 are redispersed in the cleaning solution, the cleaning efficiency can be further improved.

[0053] Next, as a liquid discharge operation, the cleaning liquid accumulated at the bottom of the container 1 is discharged while the magnetic beads 2 are fixed to the inner wall of the container 1. By supplying and discharging the cleaning liquid at least once, the magnetic beads 2 are cleaned. In this way, foreign matter can be removed with high precision.

[0054] The washing liquid is not particularly limited as long as it does not promote the elution of nucleic acids and does not promote the binding of foreign substances to the magnetic beads 2. Examples thereof include organic solvents such as ethanol, isopropanol, and acetone, or aqueous solutions thereof, and low-salt aqueous solutions.

[0055] The cleaning solution may contain a surfactant such as Triton (registered trademark), Tween (registered trademark), SDS, etc. In addition, the cleaning solution may contain a chaotropic substance such as guanidine hydrochloride.

[0056] In addition, the cleaning step S108 may be performed as needed, and may be omitted when cleaning is not necessary.

[0057] 1.3. Dissolution process

[0058] In the elution step S110, the nucleic acid adsorbed on the magnetic beads 2 is eluted into the eluent. Elution is an operation of bringing the magnetic beads 2 adsorbed with the nucleic acid into contact with the eluent and then separating from the eluent again to transfer the nucleic acid into the eluent.

[0059] Specifically, after the eluate is placed in the container 1 containing the magnetic beads 2 adsorbing the nucleic acid, the aforementioned magnetic separation operation and liquid discharge operation are performed again.

[0060] Wherein, in the magnetic separation operation, first, dissolution solution is supplied into the container 1 by a pipette or the like. Then, the magnetic beads 2 and the dissolution solution are stirred. Thus, the dissolution solution contacts the magnetic beads 2, and the nucleic acid is dissolved into the dissolution solution. During stirring, for example, a vortex mixer, a manual oscillator, a pipette or the like is used. In addition, at this time, the application of the external magnetic field can also be temporarily turned off. Thus, since the magnetic beads 2 are dispersed in the dissolution solution, the dissolution efficiency can be further improved.

[0061] Next, as a liquid discharge operation, the eluate accumulated at the bottom of the container 1 is discharged while the magnetic beads 2 are fixed to the inner wall of the container 1. In this way, the recovery liquid containing the nucleic acid can be recovered.

[0062] The elution liquid is not particularly limited as long as it is a liquid that promotes the elution of nucleic acids from the magnetic beads 2 adsorbed with nucleic acids. For example, in addition to water such as sterile water or pure water, it is preferred to use TE buffer, which is an aqueous solution containing 10mM Tris hydrochloric acid buffer and 1mM EDTA with a pH of about 8.

[0063] The eluent may contain a surfactant such as Triton (registered trademark), Tween (registered trademark), or SDS. In addition, it may contain sodium azide as a preservative.

[0064] In addition, in the elution step S110, the eluate may be heated. This can promote the elution of the nucleic acid. The heating temperature of the eluate is not particularly limited, but is preferably 70° C. to 200° C., more preferably 80° C. to 150° C., and even more preferably 95° C. to 125° C.

[0065] 2. Magnetic beads

[0066] Next, the magnetic beads 2 will be described. The magnetic beads 2 are particles that have magnetism and have a property of binding to biological substances on the surface.

[0067] Figure 7 It is a cross-sectional view showing the magnetic bead 2 according to the embodiment. Figure 7 The magnetic beads 2 shown have magnetic metal particles 22 and a covering film 24. The magnetic metal particles 22 use magnetic metal powder. Therefore, the magnetic metal particles 22 are highly magnetized in the magnetic field, which helps to increase the moving speed of the magnetic beads 2. As a result, the time required for magnetic separation can be shortened.

[0068] In addition, the covering film 24 contains inorganic oxides, so it has binding properties with biological substances. In addition, the covering film 24 contains inorganic oxides, so it has high functions of protecting the magnetic metal particles 22 from oxidation or corrosion. Therefore, the dissolution of metal ions in the magnetic beads 2 can be suppressed.

[0069] In the above-mentioned magnetic separation operation, a particle group is used which is an aggregate of such magnetic beads 2. It should be noted that the magnetic beads 2 in this specification refer to a particle group or one particle constituting the particle group.

[0070] 2.1. Characteristics of magnetic beads

[0071] 2.1.1. Metal ion concentration of the supernatant produced by the hydrochloric acid immersion test

[0072] When the magnetic beads 2 are supplied with the hydrochloric acid immersion test of the regulations shown below, the metal ion concentration of the supernatant produced is more than 0.01ppm and less than 5.00ppm in terms of mass ratio. Such magnetic beads 2 are optimized because the metal ion concentration can suppress the metal ion concentration from being too high and hindering the extraction of biological substances. Therefore, by making the metal ion concentration of the supernatant produced in the hydrochloric acid immersion test within the described range, the magnetic beads 2 with high extraction efficiency of biological substances can be obtained.

[0073] The prescribed hydrochloric acid immersion test has the following operations (1) to (3).

[0074] (1) 0.1 g of ethylenediaminetetraacetic acid (EDTA), 5 mL of pure water, and 100 mg of magnetic beads 2 were mixed to prepare a first mixture.

[0075] (2) After the first mixture and 5 mL of 10 mM hydrochloric acid were mixed to obtain a second mixture, the second mixture was stirred for 30 minutes using a vortex mixer.

[0076] (3) After the stirred second mixture was allowed to stand for 1 day, the supernatant was collected and the metal ion concentration of the supernatant was measured by high-frequency inductively coupled plasma (ICP) emission spectrometry.

[0077] By subjecting the magnetic beads 2 to the hydrochloric acid immersion test having such operations (1) to (3), the metal ion concentration of the supernatant can be measured. The metal ion concentration of the supernatant measured is 0.01 ppm or more and 5.00 ppm or less, preferably 0.10 ppm or more and 4.00 ppm or less, and more preferably 0.50 ppm or more and 3.00 ppm or less, as described above.

[0078] When the metal ion concentration of the supernatant exceeds the upper limit, since the corrosion resistance of the magnetic beads 2 is low, metal ions also dissolve in large quantities when the biological substance is taken out in the dissolution and adsorption process S102. The metal ions form a complex with the components contained in the dissolution and adsorption liquid, hindering the adsorption of the biological substance to the magnetic beads 2. On the other hand, in order to make the metal ion concentration of the supernatant lower than the lower limit, it is necessary to improve the corrosion resistance of the magnetic beads 2, especially to thicken the covering film 24, and it is possible that the magnetic properties of the magnetic metal particles 22 are reduced. In addition, it is found that when the metal ion concentration is lower than the lower limit, the adsorbed biological substance is difficult to dissolve. In this case, the yield of the biological substance is reduced.

[0079] Therefore, from the viewpoint of improving the extraction efficiency of biological substances by the magnetic beads 2, it is useful that the metal ion concentration of the supernatant is within the above range.

[0080] The metal ion concentration of the supernatant can be adjusted according to the composition or metal structure of the magnetic metal particles 22, the thickness or composition of the coating 24, etc. For example, by increasing the thickness of the coating 24, the metal ion concentration of the supernatant can be reduced.

[0081] 2.1.2.Magnetic properties

[0082] The saturation magnetization of magnetic beads 2 is preferably more than 50emu / g, more preferably more than 80emu / g, and further preferably more than 100emu / g. Saturation magnetization refers to the value of magnetization when the magnetization represented by the magnetic material is constant regardless of the magnetic field when applying a sufficiently large magnetic field from the outside. If the saturation magnetization is within the scope, the function as the magnetic material can be fully exerted. Specifically, owing to the mobile speed of the magnetic beads 2 in the magnetic field can be improved, it is possible to achieve the shortening of the time required for magnetic separation. In addition, the adsorption force when the saturation magnetization of magnetic beads 2 is fixed by the external magnetic field. If the saturation magnetization is within the scope, then a sufficiently high adsorption force can be obtained, therefore when discharging liquid 3 under the state of fixing magnetic beads 2, magnetic beads 2 can be suppressed from being discharged together with liquid 3. Thus, the reduction of the yield of the biological substance accompanied by the reduction of magnetic beads 2 can be suppressed.

[0083] The upper limit of the saturation magnetization of the magnetic beads 2 is not particularly limited, but is preferably 220 emu / g or less from the viewpoint of ease of material selection suitable for a balance between performance and cost.

[0084] The saturation magnetization of the magnetic beads 2 can be measured by a vibrating sample magnetometer (VSM) or the like. Examples of the vibrating sample magnetometer include TM-VSM1230-MHHL manufactured by Tamagawa Seisakusho Co., Ltd. The maximum applied magnetic field when measuring the saturation magnetization is, for example, 0.5 T or more.

[0085] In addition, the coercive force Hc of magnetic bead 2 is preferably below 1500A / m, more preferably below 800A / m, further preferably below 400A / m, and particularly preferably below 100A / m. Coercive force Hc refers to the value of the external magnetic field in the opposite direction required for the magnetized magnetic body to return to the state that is not magnetized. That is, coercive force Hc refers to the resistance to the external magnetic field. The smaller the coercive force Hc of magnetic bead 2, even if it is switched from the state where a magnetic field is applied to the state where a magnetic field is not applied, the more difficult it is for magnetic beads 2 to condense each other, and magnetic beads 2 can be uniformly dispersed in the dispersion. In addition, even in the case of repeatedly switching the magnetic field applied, the more excellent the redispersibility of magnetic beads 2 is because the coercive magnetic force Hc is smaller, the more excellent it is, so the condensation of magnetic beads 2 each other can be further suppressed. It should be noted that the lower limit of the coercive force Hc of magnetic bead 2 is not particularly limited, but from the viewpoint of the ease of material selection suitable for the balance of performance and cost, it is preferably more than 5A / m.

[0086] Similar to the above-mentioned saturation magnetization, the coercive force Hc of the magnetic beads can be measured by a vibrating sample magnetometer, etc. The maximum applied magnetic field when measuring the coercive force Hc is, for example, 15 kOe.

[0087] In addition, the relative magnetic permeability of the magnetic beads 2 is preferably greater than 5. When the relative magnetic permeability of the magnetic beads 2 is lower than the lower limit, the responsiveness of the magnetic beads 2 is reduced, and the time required for magnetic separation may be prolonged. It should be noted that the upper limit of the relative magnetic permeability of the magnetic beads 2 is not particularly limited, but since the magnetic beads 2 are in powder form, the relative magnetic permeability is substantially mostly less than 100 due to the influence of the diamagnetic field.

[0088] 2.1.3.Powder characteristics

[0089] The average particle size D50 of magnetic beads 2 is preferably 0.5 μm or more and 15 μm or less, more preferably 1 μm or more and 10 μm or less, further preferably 2 μm or more and 8 μm or less, and particularly preferably 2 μm or more and 6 μm or less. If the average particle size D50 of magnetic beads 2 is within the range, the specific surface area of ​​magnetic beads 2 can be fully increased, and magnetic beads 2 can be made to produce attractive forces and adsorption forces suitable for magnetic separation. In addition, the aggregation of magnetic beads 2 can be suppressed and the dispersibility can be improved. It should be noted that when the average particle size D50 of magnetic beads 2 is lower than the lower limit, the magnetization value of magnetic beads 2 becomes smaller and is easy to aggregate, as a result, it is possible that the extraction efficiency of biological substances is reduced. In addition, the moving speed of magnetic beads 2 is reduced, and the time required for magnetic separation may be longer. On the other hand, when the average particle size D50 of magnetic beads 2 is higher than the upper limit, the specific surface area of ​​magnetic beads 2 becomes smaller, so it is impossible to adsorb a sufficient amount of biological substances, and the extraction amount of biological substances may be reduced. In addition, the magnetic beads 2 are easily precipitated, and the number of magnetic beads 2 that can contribute to the extraction of biological substances is reduced, and there is a possibility that the extraction efficiency of biological substances is reduced.

[0090] It should be noted that the average particle size D50 of the magnetic beads 2 can be determined by the particle size distribution of the volume basis by the laser diffraction dispersion method, and is obtained by the cumulative distribution curve obtained from the particle size distribution. Specifically, in the cumulative distribution curve, the particle size (median particle size) with a cumulative value of 50% starting from the small diameter side is the average particle size D50 of the magnetic beads 2. As a device for measuring the particle size distribution by the laser diffraction dispersion method, for example, the MT3300 series manufactured by Microtrac Bell can be cited. It should be noted that it is not limited to the laser diffraction dispersion method, and methods such as image analysis can also be used.

[0091] In addition, the 90% particle size of the magnetic beads 2 is set to D90. In the magnetic beads 2, the ratio D90 / D50 of the 90% particle size D90 to the average particle size D50 is preferably 3.00 or less, more preferably 2.00 or less, and further preferably 1.75 or less. As a result, the content of coarse particles decreases, so the coarse particles attract the surrounding smaller particles and condense, which can suppress the generation of agglomerates. If agglomerates are generated, they settle due to their own weight, which may lead to a reduction in extraction efficiency or a prolonged inspection time for biological substances. Therefore, if the ratio D90 / D50 is within the range, the occurrence of these problems can be suppressed. It should be noted that if the ratio D90 / D50 is higher than the upper limit value, the content of coarse particles increases, so even if the application of the external magnetic field is stopped, the dispersibility of the magnetic beads 2 will decrease, and agglomeration may occur easily.

[0092] It should be noted that the 90% particle size D90 of the magnetic beads 2 can be obtained by measuring the volume-based particle size distribution by laser diffraction dispersion method, and by obtaining a cumulative distribution curve obtained from the particle size distribution. Specifically, in the cumulative distribution curve, the particle size with a cumulative value of 90% from the small diameter side is the 90% particle size D90 of the magnetic beads 2.

[0093] 2.2. Structure of magnetic beads

[0094] As mentioned above, Figure 7 The magnetic bead 2 shown has magnetic metal particles 22 and a cover film 24. Hereinafter, each part will be described.

[0095] 2.2.1. Magnetic metal particles

[0096] The magnetic metal particles 22 are metal particles having magnetism, and preferably contain at least one of Fe, Co, and Ni as a constituent element. Thus, the magnetic beads 2 having high magnetization derived from the magnetic metal can be obtained.

[0097] In particular, from the perspective of obtaining high saturation magnetization, the composition of the magnetic metal particles 22 is preferably an alloy with Fe as the main component (Fe-based alloy). Specifically, it is more preferred to make Fe more than 50% in terms of atomic ratio, and more preferably more than 70%. As Fe-based alloys, Fe-Co-based alloys, Fe-Ni-based alloys, Fe-Co-Ni-based alloys, or compounds containing Fe, Co, and Ni can be exemplified. In addition, from the perspective of obtaining high magnetization, carbonyl iron powder consisting essentially of 100% by mass of Fe can also be used as the magnetic metal particles 22. According to such an Fe-based alloy, even if the particle size is small, it is possible to achieve magnetic metal particles 22 with high saturation magnetization and high magnetic permeability. As a result, it is possible to achieve magnetic beads 2 with high moving speed caused by the action of an external magnetic field and large attraction when captured by an external magnetic field. As a result, the time required for magnetic separation can be shortened, and the magnetic beads 2 themselves can be prevented from being mixed into the eluate and becoming inclusions.

[0098] In addition to the above-mentioned Fe, which is an element that exhibits strong magnetism alone, the Fe-based alloy may contain one or more selected from the group consisting of Cr, Nb, Cu, Al, Mn, Mo, Si, Sn, B, C, P, Ti and Zr, depending on the target properties. Si is the main constituent element in the alloy powder, but is also an element that promotes amorphization.

[0099] It should be noted that the Fe-based alloy may contain impurities within a range that does not impair the effect of the magnetic metal particles 22. The impurities in this embodiment refer to elements accidentally mixed in when manufacturing the raw materials of the magnetic metal particles 22 or the magnetic beads 2. The impurities are not particularly limited, and examples thereof include O, N, S, Na, Mg, and K.

[0100] As an example of Fe-based alloys, alloys having a Si content of preferably 1.0 atomic % to 30.0 atomic %, more preferably 1.5 atomic % to 14.0 atomic %, and further preferably 2.0 atomic % to 7.0 atomic %. Such alloys have a tendency to have a high saturation magnetization due to their high magnetic permeability.

[0101] In addition, the Fe-based alloy may contain at least one of B (boron) with a content preferably of 5.0 atomic % or more and 16.0 atomic % or less, more preferably 8.0 atomic % or more and 13.0 atomic % or less, and C (carbon) with a content preferably of 0.5 atomic % or more and 5.0 atomic % or less, more preferably 1.5 atomic % or more and 4.0 atomic % or less. They are elements that promote amorphization and contribute to the formation of a stable amorphous structure or nanocrystalline structure on the magnetic metal particles 22. Thus, a magnetic metal particle 22 with low coercivity can be obtained.

[0102] In addition, the Fe-based alloy preferably contains Cr (chromium) at a content of 1.0 atomic % or more and 8.0 atomic % or less, and more preferably contains Cr at a content of 1.5 atomic % or more and 5.0 atomic % or less. This can improve the corrosion resistance of the magnetic metal particles 22. As a result, the magnetic metal particles 22 in which the dissolution of metal ions is suppressed can be obtained.

[0103] It should be noted that the content of impurities is preferably 1.0 atomic % or less in total. If it is within this range, even if impurities are contained, the effect of the magnetic metal particles 22 is not impaired.

[0104] The constituent elements and composition of the magnetic metal particles 22 can be specified by the inductively coupled plasma luminescence analysis method specified in JIS G 1258: 2014, the spark luminescence analysis method specified in JIS G 1253: 2002, and the like. In addition, when the magnetic metal particles 22 are covered with the covering film 24, the covering film 24 can be removed by a chemical or physical method and then measured by the above method. In addition, when it is difficult to remove the covering film 24, for example, after cutting the magnetic beads 2, the part of the magnetic metal particles 22 that serve as the magnetic core can be analyzed by an analysis device such as EPMA (Electron Probe Micro Analyzer) or EDX (Energy Dispersive X-ray spectroscopy).

[0105] The Vickers hardness of the magnetic metal particles 22 is preferably 100 or more, more preferably 300 or more, and further preferably 800 or more. The method for measuring the hardness of the magnetic metal particles 22 is as follows. After taking out a plurality of magnetic metal particles 22 and filling them in a resin to prepare a resin-filled sample, the cross section of the magnetic metal particles 22 is made to appear on the surface of the resin-filled sample by grinding and polishing. An indentation is applied to it by a micro-Vickers tester or a nano-indenter, and the hardness is measured by its size.

[0106] It should be noted that, when the Vickers hardness of the magnetic metal particle 22 is less than the lower limit, the magnetic metal particle 22 may be plastically deformed due to the impact when colliding with the magnetic bead 2. In the case of plastic deformation, the covering film 24 may be peeled off or fall off. It should be noted that the upper limit of the Vickers hardness is not particularly limited, but from the perspective of ease of material selection suitable for performance or cost balance, it is preferably 3000 or less.

[0107] The main metal structure constituting the magnetic metal particles 22 can be in various forms such as crystalline structure, amorphous structure, nanocrystalline structure, etc. Amorphous structure refers to an amorphous structure without crystallization, and nanocrystalline refers to a structure mainly composed of fine crystals with a crystal grain size of less than 100nm. Amorphous structure and nanocrystalline structure give the magnetic metal particles 22 high hardness. In addition, by forming amorphous structure or nanocrystalline structure, the coercive force Hc of the magnetic beads 2 becomes a particularly low value, which helps to improve the redispersibility of the magnetic beads 2. It should be noted that the volume fraction of amorphous structure or nanocrystalline structure in the magnetic metal particles 22 is preferably 40% or more, and more preferably 60% or more. The volume fraction is obtained by the result of crystal structure analysis using X-ray diffraction. In addition, crystalline structure, amorphous structure and nanocrystalline structure can exist separately, or two or more of them can be mixed.

[0108] The metal structure of the magnetic metal particle 22 can be identified by analyzing the crystal structure of the magnetic metal particle 22 using the X-ray diffraction method. Furthermore, it can be determined by analyzing the sample cut out by using a transmission electron microscope (TEM) to observe the image or diffraction pattern. For example, in the case of an amorphous structure, in the peak analysis of the X-ray diffraction method, the diffraction peak of the metal crystal derived from the α-Fe phase is not seen. In addition, in the case of an amorphous structure, a so-called halo pattern is formed in the electron beam diffraction pattern of the TEM, and the light spots formed by the crystal are not seen. The nanocrystalline structure is composed of a crystalline structure with a particle size of, for example, less than 100nm, which can be confirmed by TEM observation images. More precisely, the average particle size can be calculated by image processing and the like from multiple TEM tissue observation images in which multiple crystals are present. In addition, the crystal grain size can be inferred by the Scherrer method based on the diffraction peak of the crystalline phase that is the object of the X-ray diffraction method. In addition, for a crystalline structure with a large particle size, the crystal grain size can be measured by methods such as observing a cross section using an optical microscope or a scanning electron microscope (SEM).

[0109] In order to obtain amorphous structure and nanocrystalline structure, when manufacturing magnetic metal particles 22, after pulverizing the molten raw material, it is effective to increase the cooling rate during cooling. In addition, the ease of formation of amorphous structure and nanocrystalline structure also depends on the alloy composition. As a specific alloy system suitable for forming amorphous structure and nanocrystalline structure, it is preferred to add one or more compositions selected from the group consisting of Cr, Si, B, C, P, Nb and Cu to Fe.

[0110] The magnetic metal particles 22 are manufactured by a method based on a general method for manufacturing metal powders. Examples of the manufacturing method include a dissolution process in which a metal is dissolved and solidified to form a powder, a chemical process in which a powder is manufactured by a reduction method or a carbonyl method, and a mechanical process in which a larger material such as an ingot is mechanically crushed to obtain a powder. Among them, the dissolution process is suitable for manufacturing the magnetic metal particles 22.

[0111] Among the manufacturing methods using the dissolution process, the atomization method can be cited as a representative manufacturing method. The atomization method is a method of rapidly solidifying and powdering a molten metal by causing the molten metal to collide with a fluid (liquid or gas) sprayed at high speed. Depending on the type of cooling medium or the structure of the device, it is divided into water atomization, high-pressure water atomization, rotating water flow atomization, gas atomization, etc. According to the atomization method, magnetic metal particles 22 can be efficiently manufactured. In addition, in the high-pressure water atomization method, the rotating water flow atomization method, and the gas atomization method, the particle shape of the metal powder is close to a spherical shape due to the effect of surface tension.

[0112] 2.2.2. Covering film

[0113] like Figure 7 As shown, the coating film 24 covers the particle surface of the magnetic metal particle 22. The coating film 24 only needs to be formed on at least a part of the particle surface of the magnetic metal particle 22, but preferably covers the entire surface of the particle.

[0114] The covering film 24 covers the particle surface of the magnetic metal particle 22 and contains an inorganic oxide. As the inorganic oxide, for example, silicon oxide, magnesium oxide, calcium oxide, aluminum oxide, titanium oxide, zirconium oxide, boron oxide, yttrium oxide, etc. can be listed, and one or a mixture of two or more of them can be used. The covering film 24 containing such an inorganic oxide becomes porous, so the specific surface area becomes larger. As a result, the amount of adsorption of biological substances to the covering film 24 can be increased.

[0115] In addition, inorganic oxide is particularly preferably silicon oxide. Silicon oxide can effectively extract and recycle biological substances by specifically adsorbing biological substances such as nucleic acid in a dissolving and adsorbing liquid. In addition, because silicon oxide is chemically stable, oxidation or corrosion of magnetic metal particles 22 can be particularly suppressed, and the corrosion resistance of magnetic microbeads 2 can be particularly improved.

[0116] Silicon oxide is represented by the composition formula SiO x (0<x≤2), preferably SiO2. In addition, silicon oxide may form a composite oxide or a composite with one or more selected from the group consisting of Al, Ti, V, Nb, Cr, Mn, Sn and Zr.

[0117] Inorganic oxides may also contain substances (impurities) other than inorganic oxides, for example, in a ratio of preferably 50% by mass or less, more preferably 10% by mass or less of the aforementioned inorganic oxides, without damaging the above-mentioned effects. For example, when silicon oxide is used as an inorganic oxide, impurities such as C, N, and P may be listed.

[0118] The composition of the inorganic oxide can be confirmed by, for example, EDX analysis, Auger electron spectroscopy, or the like.

[0119] The average thickness of the covering film 24 is preferably more than 15nm, more preferably more than 20nm, and further preferably more than 30nm. Thus, even if there is a collision between the magnetic beads 2 or a collision with the inner wall of the container, the covering film 24 can be suppressed from being destroyed or peeled off. As a result, the dissolution of the metal ions etc. exposed by the magnetic metal particles 22 can be suppressed. On the other hand, the average thickness of the covering film 24 is preferably less than 500nm, more preferably less than 200nm, and further preferably less than 150nm. Thus, the magnetization per unit volume possessed by the magnetic beads 2 can be suppressed to reduce, and the moving speed of the magnetic beads 2 can be suppressed to reduce.

[0120] In addition, when the average thickness of the covering film 24 is set to t and the average particle size of the magnetic beads 2 is set to D50, the ratio t / D50 of t to D50 is preferably greater than 0.0001 and less than 0.05, more preferably greater than 0.001 and less than 0.04, and further preferably greater than 0.005 and less than 0.03. When t / D50 is lower than the lower limit, since the ratio of the thickness of the covering film 24 to the size of the magnetic metal particles 22 becomes too small, the covering film 24 may be damaged or peeled off when the magnetic beads 2 collide with each other or when the magnetic beads 2 collide with the inner wall of the container 1. Therefore, the amount of biological substances adsorbed on the surface of the covering film 24 and extracted is reduced, and the extraction efficiency may be reduced. In addition, if the peeled-off fragments of the covering film 24 or the magnetic metal particles 22 are present in the extract, they may be mixed in as inclusions (contaminants) when the biological substances are taken out. In addition, because the covering film 24 is destroyed and peeled off, the magnetic metal particles 22 are exposed, and when in contact with an acidic solution, the dissolution of metal ions etc. is caused, and as a result, the extraction efficiency of biological substances may be reduced. On the other hand, when t / D50 is higher than the upper limit, the volume ratio of the covering film 24 in the whole volume of the magnetic beads 2 becomes larger, and the magnetization per unit volume possessed by the magnetic beads 2 may be reduced. Thus, the mobile speed when the external magnetic field acts on the magnetic beads 2 is reduced, and the time required for magnetic separation may be lengthened.

[0121] The thickness of the covering film 24 can be measured, for example, by observing the cross-section image of the magnetic bead 2 using a transmission electron microscope or a scanning electron microscope. In addition, the average thickness t of the covering film 24 can be calculated by obtaining a plurality of observation images and averaging the measured values ​​from image processing and the like. For example, the average thickness t is a value obtained by measuring the thickness of the covering film 24 at more than 5 locations on one magnetic bead 2, and then averaging the average value using more than 10 magnetic beads 2. In addition, the thickness of the covering film 24 can be calculated based on the comparison result by comparing the intensity of, for example, Si-K characteristic X-rays or Fe-L characteristic X-rays using an analysis device such as EDX (Energy Dispersive X-ray spectroscopy). That is, as described later, when the covering film 24 contains silicon and the magnetic metal particles 22 are composed of an Fe-based alloy, the intensity ratio of the Si-K characteristic X-rays originating from the covering film 24 to the sum of the Fe-L characteristic X-rays originating from the magnetic metal particles 22 and the Si-K characteristic X-rays originating from the covering film 24 can be converted into the thickness of the covering film 24.

[0122] As a method for forming the covering film 24, for example, a wet forming method such as a sol-gel method and a dry forming method such as a vapor phase film forming method can be cited. Among them, the Stober method and the ALD (Atomic Layer Deposition) method, which are a type of sol-gel method, can be preferably used. The Stober method is a method for forming monodisperse particles by hydrolysis of metal alkoxides. For example, in the case where the covering film 24 is formed by silicon oxide, silicon oxide can be generated by a hydrolysis reaction of silicon alkoxides. It should be noted that before forming the covering film 24, the surface of its substrate, such as the surface of the particles of the magnetic metal particles 22, may be cleaned using water or an organic solvent.

[0123] It should be noted that the covering film 24 may cover the surface of one magnetic metal particle 22 or may cover a plurality of magnetic metal particles 22 collectively.

[0124] Figure 8 Yes means Figure 7 A cross-sectional view of a modified example of the magnetic bead 2.

[0125] Figure 8 The magnetic bead 2A shown in the figure includes a plurality of magnetic metal particles 22. In addition, a covering film 24 is provided in a manner covering the plurality of magnetic metal particles 22. Such a magnetic bead 2A can also be obtained in the same manner as Figure 7 The same effect is shown for magnetic beads 2.

[0126] The number of magnetic metal particles 22 included in the magnetic bead 2A is not particularly limited, but is 2 or more and 100 or less.

[0127] 3. Magnetic Bead Dispersion

[0128] Next, the magnetic bead dispersion 4 according to the embodiment will be described. As described above, Figure 2 The magnetic bead dispersion 4 shown contains magnetic beads 2 and a dispersion medium 40 .

[0129] Examples of the dispersion medium 40 include water, saline, polar organic solvents such as alcohols, or aqueous solutions thereof. Examples of water include sterilized water and pure water. Examples of alcohols include ethanol and isopropyl alcohol.

[0130] The concentration of the magnetic beads 2 in the magnetic bead dispersion 4 is not particularly limited as long as it is a concentration that can ensure sufficient uniformity by stirring the magnetic bead dispersion 4 .

[0131] A surfactant may be added to improve the dispersibility of the magnetic beads 2 in the magnetic bead dispersion 4. Examples of the surfactant include nonionic surfactants, cationic surfactants, anionic surfactants, and zwitterionic surfactants.

[0132] As nonionic surfactants, for example, Triton-based surfactants such as Triton (registered trademark)-X, Tween-based surfactants such as Tween (registered trademark) 20, acyl sorbitan, etc. can be listed. As cationic surfactants, for example, dodecyl trimethyl ammonium bromide, dodecyl trimethyl ammonium chloride, hexadecyl trimethyl ammonium bromide, etc. can be listed. As anionic surfactants, for example, sodium lauryl sulfate, sodium N-lauroyl sarcosine (SDS), sodium cholate, sodium lauryl sulfate, sarcosine, etc. can be listed. As zwitterionic surfactants, for example, phosphatidylethanolamine, etc. can be listed. These surfactants can be used alone or in combination of two or more.

[0133] The content of the surfactant in the magnetic bead dispersion 4 is preferably above the critical micelle concentration of the surfactant. Critical micelle concentration is also referred to as cmc (critical micelle concentration), which refers to the concentration when the molecules of the surfactant dispersed in the liquid are assembled to form micelles. By making the content of the surfactant above the critical micelle concentration, the surfactant is easy to form a layer around the magnetic beads 2. Thus, the effect of suppressing the aggregation of the magnetic beads 2 can be further improved.

[0134] It should be noted that the content of the surfactant is not limited to above the critical micelle concentration, and may be less than the critical micelle concentration. For example, the content of the surfactant in the magnetic bead dispersion 4 is independent of the critical micelle concentration, and is preferably above 0.05 mass % and below 3.0 mass %.

[0135] In addition, in order to make the magnetic bead dispersion liquid 4 have long-term storage and antiseptic effect, it is preferred to add an antiseptic. As the antiseptic, sodium azide etc. can be listed. The added concentration of the antiseptic is preferably 0.02 mass % or more and less than 0.1 mass % of the magnetic bead dispersion liquid 4. When it is less than 0.02 mass %, it is possible that sufficient effect cannot be obtained in terms of long-term storage and antiseptic, and when it is more than 0.1 mass %, it is possible to produce technical problems such as reducing the extraction efficiency of biological substances.

[0136] In addition, a buffer may be added for the purpose of adjusting the pH. Examples of the buffer include Tris buffer and the like.

[0137] 4. Effects of the Implementation Methods

[0138] As described above, the magnetic beads 2 involved in the embodiment have magnetic metal particles 22 and a covering film 24. The covering film 24 covers the surface of the magnetic metal particles 22, contains an inorganic oxide, and has an average thickness of 15 nm or more. In addition, the metal ion concentration of the supernatant obtained by the magnetic beads 2 through the following operation is greater than 0.01 ppm and less than 5.00 ppm. The following operation refers to: mixing 0.1 g of ethylenediaminetetraacetic acid (EDTA), 5 mL of pure water and 100 mg of magnetic beads 2 to prepare a first mixture; after mixing the first mixture with 5 mL of hydrochloric acid at a concentration of 10 mM to obtain a second mixture, the second mixture is stirred for 30 minutes with a vortex mixer; and after the stirred second mixture is left to stand for 1 day, the supernatant is collected and the metal ion concentration of the supernatant is determined by high-frequency inductively coupled plasma (ICP) emission spectrometry.

[0139] According to such a structure, since the magnetic metal particles 22 have high magnetization derived from the magnetic metal, it is possible to obtain magnetic beads 2 that have a high moving speed caused by the action of the external magnetic field and can quickly perform magnetic separation. In addition, since the metal ion concentration of the supernatant obtained by the above-mentioned operation is optimized, it is possible to obtain magnetic beads 2 with high extraction efficiency of biological substances.

[0140] In addition, the inorganic oxide is preferably silicon oxide.

[0141] Since silicon oxide is chemically stable, it can particularly suppress oxidation and corrosion of magnetic metal particles 22, and can particularly improve the corrosion resistance of magnetic beads 2. In addition, silicon oxide can efficiently extract and recover biological substances by specifically adsorbing biological substances such as nucleic acids in a dissolving and adsorbing solution.

[0142] In addition, the magnetic metal particles 22 are preferably made of an Fe-based alloy.

[0143] According to such a structure, even if the particle size is small, it is possible to realize magnetic metal particles 22 having high saturation magnetization and high magnetic permeability. Thus, it is possible to realize magnetic beads 2 having high moving speed caused by the action of the external magnetic field and strong attraction when captured by the external magnetic field. As a result, it is possible to shorten the time required for magnetic separation, and it is possible to prevent the magnetic beads 2 themselves from being mixed into the eluate and becoming inclusions.

[0144] Furthermore, the Fe-based alloy preferably contains Fe as a main component and one or two or more selected from the group consisting of Cr, Si, B, C, P, Nb, and Cu.

[0145] Thus, a Fe-based alloy that can easily form an amorphous structure or a nanocrystalline structure can be obtained. As a result, a magnetic bead 2 having a low coercive force and excellent redispersibility can be realized.

[0146] In addition, the magnetic metal particles 22 preferably include an amorphous structure.

[0147] According to such a configuration, it is possible to obtain magnetic beads 2 having low coercivity and excellent redispersibility.

[0148] In addition, in a cumulative distribution curve obtained from a volume-based particle size distribution, a particle diameter D50 at which the cumulative value from the smaller diameter side is 50% is preferably 0.5 μm or more and 15 μm or less.

[0149] According to such a structure, the specific surface area of ​​the magnetic beads 2 can be sufficiently increased, and the magnetic beads 2 can generate attractive force and adsorption force suitable for magnetic separation. In addition, the aggregation of the magnetic beads 2 can be suppressed, and the dispersibility can be improved.

[0150] In addition, the ratio t / D50 of the average thickness t of the coating 24 to the particle diameter D50 is preferably 0.0001 or more and 0.05 or less.

[0151] According to such a structure, the peeling of the covering film 24 accompanied by the collision of the magnetic beads 2 can be suppressed. In addition, the dissolution of metal ions can be suppressed. In addition, the magnetization reduction per unit volume of the magnetic beads 2 can be suppressed. As a result, magnetic separation can be performed more quickly, and the magnetic beads 2 with higher extraction efficiency of biological substances can be obtained.

[0152] Furthermore, the magnetic bead dispersion 4 as the magnetic bead reagent according to the above embodiment contains the magnetic beads 2 and a dispersion medium 40 for dispersing the magnetic beads 2 .

[0153] According to such a structure, since the magnetic metal particles 22 have high magnetization derived from the magnetic metal, a magnetic bead dispersion 4 can be obtained that has a high migration speed caused by the action of the external magnetic field and can quickly perform magnetic separation. In addition, since the metal ion concentration of the supernatant obtained by the above operation is optimized, a magnetic bead dispersion 4 with high extraction efficiency of biological substances can be obtained.

[0154] The magnetic beads and magnetic bead reagent of the present invention have been described above based on the illustrated embodiments, but the present invention is not limited thereto. For example, the magnetic beads and magnetic bead reagent of the present invention may be supplemented with any component in the above embodiments.

[0155] Example

[0156] Next, specific examples of the present invention will be described.

[0157] 5. Preparation of magnetic beads

[0158] First, magnetic metal particles made of a soft magnetic material having a composition shown in Table 1 were prepared by high-pressure water atomization. Then, the metal structure of the obtained magnetic metal particles was analyzed by X-ray diffraction. The metal structure determined by the analysis is shown in Table 1.

[0159] [Table 1]

[0160] Soft magnetic materials Metal structure Composition formula (atomic ratio) 1 Amorphous <![CDATA[Fe 81 Si5B 12 C2]]> 2 Amorphous <![CDATA[Fe 73 Yes 11 Cr2B 11 C3]]> 3 Amorphous <![CDATA[Fe 73.5 Yes 13.5 Cu1B9Nb3]]> 4 Crystalline <![CDATA[Fe 88.6 Yes 6.7 Cr 4.7 ]]>

[0161] Next, a silicon oxide (SiO2) film is formed on the surface of the magnetic metal particles by the Stober method to obtain a covering film. In Stober, first, 100g of magnetic metal powder is dispersed in 950mL of ethanol and mixed, and the mixture is stirred for 20 minutes by an ultrasonic applicator. After stirring, a mixed solution of 30mL of pure water and 180mL of ammonia water is added and stirred for another 10 minutes. Then, a mixed solution of tetraethoxysilane (TEOS) and 100mL of ethanol is added and stirred to form a covering film on the surface of the magnetic metal particles. It should be noted that the formation time in this case is 30 minutes, but the formation time is changed according to the thickness to be formed. Then, the obtained covering film was washed with ethanol and acetone, respectively. After washing, it was dried at 65°C for 30 minutes and then heated at 200°C for 90 minutes. Thus, the magnetic beads of samples No. 1 to 32 shown in Tables 2 to 6 were obtained.

[0162] It should be noted that in the preparation of the magnetic beads of sample No. 29, tetraethoxytitanium was used as the metal alkoxide.

[0163] In addition, the saturation magnetization and coercive force of the magnetic beads are shown in Tables 2 to 6.

[0164] 6. Determination of Metal Ion Concentration in Supernatant

[0165] The magnetic beads of sample Nos. 1 to 25 were subjected to the above-described predetermined hydrochloric acid immersion test. Then, the metal ion concentration of the generated supernatant was measured. The measurement results are shown in Tables 2 to 5.

[0166] In addition, in Tables 2 to 5, magnetic beads corresponding to the present invention are referred to as "Examples", and magnetic beads not corresponding to the present invention are referred to as "Comparative Examples".

[0167] 7. Preparation of Magnetic Bead Suspension for Evaluation

[0168] The magnetic beads of sample Nos. 26 to 32 were added to pure water containing iron sulfate to prepare magnetic bead suspensions. The amount of iron sulfate added in the obtained magnetic bead suspensions was adjusted so that the metal ion concentrations would be the concentrations shown in Table 6.

[0169] Note that since Sample Nos. 26 to 32 are magnetic bead suspensions in which the metal ion concentration is intentionally adjusted using iron sulfate, they are listed as “reference examples” for evaluation in Table 6.

[0170] 8. Evaluation of magnetic beads

[0171] 8.1. Recovery and yield of nucleic acid

[0172] First, human genomic DNA was prepared as a model of nucleic acid, and lysozyme was prepared as a model of inclusion.

[0173] Next, the magnetic beads of each embodiment and each comparative example were dispersed in pure water, stirred and prepared into a magnetic bead suspension. In addition, the magnetic bead suspension of each reference example (sample No. 26 to 32) was used directly. It should be noted that the content of magnetic beads in the magnetic bead suspension was 53.17% by mass.

[0174] Next, after the reagents other than the nucleic acid were left to cool to room temperature, the reagents were added to the tube in the following order.

[0175] ·Pure water 10μL

[0176] 75 μL of nucleic acid dispersion at a concentration of 0.1 μg / μL

[0177] Dissolution and adsorption solution 750μL

[0178] 15 μL of 10 μg / μL lysozyme aqueous solution

[0179] · Magnetic bead suspension 40μL

[0180] Next, the contents of the tube were stirred with a vortex mixer for 10 minutes, and then the tube was placed on a magnetic stand for 30 seconds. The magnetic beads were then magnetically captured, and the supernatant was removed.

[0181] Next, 900 μL of washing solution was added to the tube, stirred with a vortex mixer for 5 seconds, and then centrifuged. Then, the tube was placed on a magnetic stand for 30 seconds. Then, the magnetic beads were magnetically captured and the supernatant was removed. Then, the washing solution was added, the magnetic capture and the supernatant were removed again.

[0182] Next, 900 μL of 70% ethanol aqueous solution was added to the tube, stirred with a vortex mixer for 5 seconds, and then centrifuged. Then, the contents of the tube were sucked back with a pipette. Then, the tube was placed on a magnetic stand for 30 seconds. Then, after magnetic capture of the magnetic beads, the supernatant was removed. Then, the ethanol aqueous solution was added, magnetic capture, and supernatant removal were performed again. Next, after the tube was centrifuged, the remaining supernatant was removed.

[0183] Next, 100 μL of pure water was added to the tube and stirred with a vortex mixer for 10 minutes to elute the nucleic acid. The tube was then placed on a magnetic stand for 30 seconds. After magnetic capture of the magnetic beads, the eluate containing the nucleic acid was recovered in another tube.

[0184] Next, the tube containing the recovered eluate is placed on an absorptiophotometer, and the nucleic acid concentration in the eluate is quantified according to the absorbance at a wavelength of 260 nm. It should be noted that since nucleic acid bases have a maximum absorption near 260 nm, the absorbance at a wavelength of 260 nm is used for the quantification of nucleic acid concentration. Then, the recovery amount of nucleic acid is calculated according to the obtained concentration. The calculation results are shown in Tables 2 to 6.

[0185] In addition, the calculated recovery amount of nucleic acid was evaluated according to the following evaluation criteria. The evaluation results are shown in Tables 2 to 6 as relative evaluation results of nucleic acid yields.

[0186] A: The recovery amount of nucleic acid is above 35ng / uL

[0187] B: The amount of nucleic acid recovered is 30 ng / uL or more and less than 35 ng / uL

[0188] C: The amount of nucleic acid recovered is 25 ng / uL or more and less than 30 ng / uL

[0189] D: The amount of nucleic acid recovered is less than 25ng / uL

[0190] 8.2. Redispersibility

[0191] First, the magnetic beads of each embodiment and each comparative example were dispersed in a PBS buffer solution to a concentration of 30 mass % to prepare a dispersion. The PBS buffer solution is a phosphate buffer solution containing 137 mmol / L NaCl, 8.1 mmol / L Na2HPO4, 2.7 mmol / L KCl, and 1.5 mmol / L KH2PO4.

[0192] Next, the prepared dispersion was placed in a laser diffraction / scattering particle size distribution measuring apparatus to measure the average particle size based on volume. The measured value of the average particle size obtained was used as the value before the separation of the target biological substance and was used as a reference value.

[0193] Next, protein A, which is a target biological substance, was dispersed in pure water to prepare a sample aqueous solution in a microtube. The concentration of protein A was 50 μg / mL.

[0194] Next, magnetic beads were dispersed in the sample aqueous solution so as to have a concentration of 30% by mass, thereby allowing the target biological substance to be adsorbed on the magnetic beads.

[0195] Next, a magnet was brought close to the side of the microtube to apply a magnetic field, and then the supernatant was removed. Then, the magnetic beads remaining in the microtube were recovered.

[0196] Next, the recovered magnetic beads were redispersed in a PBS buffer aqueous solution to prepare a redispersed liquid.

[0197] Next, the prepared redispersion liquid was placed in a laser diffraction / scattering particle size distribution measuring apparatus to measure the average particle size on a volume basis. The obtained average particle size was used as the value after the separation process of the target biological substance.

[0198] Next, the ratio of the value after the separation operation to the reference value was calculated. It can be said that the closer the ratio is to 1.0, the better the redispersibility of the magnetic beads. Next, the calculated ratio was evaluated according to the following evaluation criteria. The evaluation results are shown in Tables 2 to 5.

[0199] A: The ratio of the value after separation operation to the reference value is less than 1.1

[0200] B: The ratio of the value after separation operation to the reference value is 1.1 or more and less than 1.5

[0201] C: The ratio of the value after separation operation / the reference value is 1.5 or more and less than 2.0

[0202] D: The ratio of the value after separation operation to the reference value is 2.0 or more

[0203] 8.3. Magnetic separation speed

[0204] First, the magnetic beads of each embodiment and each comparative example were dispersed in pure water at 25°C to a concentration of 0.1% by mass to prepare a dispersion. Next, the dispersion was placed in a spectroscopic unit and stirred using a vortex mixer. The stirring time was 1 minute. Next, the spectroscopic unit that had been stirred was quickly set on the unit holder of the spectrophotometer. It should be noted that a magnet was pre-installed on the unit holder according to the position of the spectroscopic unit. In addition, the shortest distance between the outer wall of the spectroscopic unit provided on the unit holder and the magnet was set to 2.0 mm, and a magnet having a surface magnetic flux density of 180 mT was used.

[0205] Next, while the spectroscopic unit was being allowed to stand, the absorbance at a wavelength of 550 nm was measured. Then, the time until the absorbance decayed to 10% of the initial absorbance was measured, and the measurement result was used as an evaluation index for evaluating the magnetic separation speed. Then, the obtained evaluation index was evaluated according to the following evaluation criteria. The evaluation results are shown in Tables 2 to 5.

[0206] A: The evaluation index of magnetic separation speed is less than 20 seconds

[0207] B: The evaluation index of magnetic separation speed is 20 seconds or more and less than 40 seconds

[0208] C: The evaluation index of magnetic separation speed is 40 seconds or more and less than 60 seconds

[0209] D: The evaluation index of magnetic separation speed is 60 seconds or more [Table 2]

[0210]

[0211] [Table 3]

[0212]

[0213] [Table 4]

[0214]

[0215] [Table 5]

[0216]

[0217] [Table 6]

[0218]

[0219] As shown in Tables 2 to 5, the yield of nucleic acid of the magnetic beads of each embodiment is good. In addition, as shown in Table 6, it can be confirmed that the metal ion concentration in the magnetic bead suspension has a significant effect on the recovery of nucleic acid. Therefore, it can be known that the magnetic beads of each embodiment that can optimize the dissolution amount of metal ions can improve the extraction efficiency of biological substances.

[0220] In addition, as shown in Table 2 to Table 5, the redispersibility of the magnetic beads of each embodiment is also good. The magnetic beads with good redispersibility are difficult to condense, so they can contribute to the increase of the adsorption amount of nucleic acid. Therefore, from the viewpoint of redispersibility, it can be said that the extraction efficiency of the biological substance of the magnetic beads of each embodiment is high.

[0221] Furthermore, the magnetic separation speed of the magnetic beads of each example was good. Therefore, it can be said that magnetic separation can be performed quickly by using the magnetic beads of each example.

Claims

1. A magnetic bead, characterized in that: The magnetic beads have: magnetic metal particles; and a covering film covering the surface of the magnetic metal particles, containing an inorganic oxide, and having an average thickness of 15 nm or more. When the magnetic beads are subjected to the following operation, the metal ion concentration of the supernatant is 0.01 ppm or more and 5.00 ppm or less: The first mixture is prepared by mixing 0.1 g of ethylenediaminetetraacetic acid (EDTA), 5 mL of pure water and 100 mg of the magnetic beads; After mixing the first mixture with 5 mL of 10 mM hydrochloric acid to obtain a second mixture, stirring the second mixture with a vortex mixer for 30 minutes; as well as After the stirred second mixture is left to stand for 1 day, the supernatant is collected and the metal ion concentration of the supernatant is measured by high-frequency inductively coupled plasma (ICP) emission spectrometry.

2. The magnetic bead according to claim 1, wherein The inorganic oxide is silicon oxide.

3. The magnetic bead according to claim 1 or 2, wherein The magnetic metal particles are composed of Fe-based alloy.

4. The magnetic bead according to claim 3, wherein The Fe-based alloy contains Fe as a main component and contains one or more selected from the group consisting of Cr, Si, B, C, P, Nb and Cu.

5. The magnetic bead according to claim 1 or 2, wherein The magnetic metal particles include an amorphous structure.

6. The magnetic bead according to claim 1 or 2, wherein In the cumulative distribution curve obtained from the volume-based particle size distribution, the particle size D50 at which the cumulative value from the small diameter side is 50% is 0.5 μm or more and 15 μm or less.

7. The magnetic bead according to claim 6, wherein A ratio t / D50 of the average thickness t of the coating film to the particle diameter D50 is greater than or equal to 0.0001 and less than or equal to 0.

05.

8. A magnetic bead reagent, characterized in that: The magnetic bead reagent contains: The magnetic beads according to claim 1 or 2; and A dispersion medium is provided to disperse the magnetic beads.

Citation Information

Patent Citations

  • Magnetic particle composition, use of magnetic particle composition in nucleic acid separation, kit for obtaining magnetic particle composition, magnetic particle, chaotropic salt, and separation and purification method

    CN114423864A

  • Magnetic bead reagent

    CN115838718A

  • Magnetic particle

    JP2005091241A

  • Magnetic beads, method of making and method of use thereof

    US20220093295A1